Armistice Capital’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-166,174
Closed -$311K 289
2023
Q2
$311K Buy
+166,174
New +$311K ﹤0.01% 168